PDI 192
Alternative Names: PDI-192Latest Information Update: 02 Aug 2017
At a glance
- Originator PreCision Dermatology
- Class Skin disorder therapies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Atopic dermatitis
Most Recent Events
- 27 Jul 2017 Valeant Pharmaceuticals International acquired Ortho Dermatologics in 2011 and changed the name of the later to Valeant Dermatology. Subsequently, in July 2017, it was rebranded to Ortho Dermatologics
- 18 Feb 2016 No development reported - Phase-II for Atopic dermatitis (In adolescents, In children) in USA (Topical)
- 08 Jul 2014 PreCision Dermatology has been acquired by Valeant Pharmaceuticals International